Enhabit, Inc. (EHAB) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $13.94. It has a SharesGrow Score of 27/100, indicating a weak investment profile with 0 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of EHAB = $9.47 (-32.1% from the current price, the stock appears overvalued). Analyst consensus target is EHAB = $14 (-2.9% upside).
Valuation: EHAB trades at a trailing Price-to-Earnings (P/E) of -154 (S&P 500 average ~25).
Financials: revenue is $1.1B, -0.7%/yr average growth. Net income is $5M (loss), growing at -32.1%/yr. Net profit margin is -0.4% (negative). Gross margin is 46.9% (-4.6 pp trend).
Balance sheet: total debt is $500M against $534M equity (Debt-to-Equity (D/E) ratio 0.94, moderate). Current ratio is 1.63 (strong liquidity). Debt-to-assets is 42.8%. Total assets: $1.2B.
Analyst outlook: 2 / 11 analysts rate EHAB as buy (18%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 35/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 50/100 (Partial), Moat 52/100 (Partial), Future 26/100 (Fail), Income 10/100 (Fail).
